Heidelberg Pharma AG (XTER:HPHA) Dividend Payout Ratio : 0.00 (As of May. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Heidelberg Pharma AG Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Heidelberg Pharma AG's Dividend Payout Ratio for the months ended in May. 2024 was 0.00.

The historical rank and industry rank for Heidelberg Pharma AG's Dividend Payout Ratio or its related term are showing as below:

XTER:HPHA's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.47
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-09-21), the Dividend Yield % of Heidelberg Pharma AG is 0.00%.

Heidelberg Pharma AG's Dividends per Share for the months ended in May. 2024 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Heidelberg Pharma AG Dividend Payout Ratio Historical Data

The historical data trend for Heidelberg Pharma AG's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heidelberg Pharma AG Dividend Payout Ratio Chart

Heidelberg Pharma AG Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Dividend Payout Ratio

Get a 7-Day Free Trial

Heidelberg Pharma AG Quarterly Data
	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Heidelberg Pharma AG's Dividend Payout Ratio

For the Biotechnology subindustry, Heidelberg Pharma AG's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Heidelberg Pharma AG's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Heidelberg Pharma AG's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Heidelberg Pharma AG's Dividend Payout Ratio falls into.

Heidelberg Pharma AG Dividend Payout Ratio Calculation

Heidelberg Pharma AG's Dividend Payout Ratio for the fiscal year that ended in Nov. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Nov. 2023 )	/	EPS without NRI (A: Nov. 2023 )
	=	0	/	-0.441
	=	N/A

Heidelberg Pharma AG's Dividend Payout Ratio for the quarter that ended in May. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: May. 2024 )	/	EPS without NRI (Q: May. 2024 )
	=	0	/	-0.09
	=	N/A

Heidelberg Pharma AG (XTER:HPHA) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Heidelberg Pharma AG Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Heidelberg Pharma AG's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Heidelberg Pharma AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heidelberg Pharma AG (XTER:HPHA) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

HPHA:Germany

Address

Gregor-Mendel-Street 22, Ladenburg, DEU, 68526

Website

https://www.heidelberg-pharma.com

Heidelberg Pharma AG is a biopharmaceutical company. It is focused on oncology and develops the toxin Amanitin into cancer therapies using its proprietary Antibody Targeted Amanitin Conjugate (ATAC) technology platform and advances the biological mode of action of the toxin as a novel therapeutic principle. The proprietary lead candidate is HDP-101 which is a BCMA (B-cell maturation antigen) - ATAC for multiple myeloma. In addition, the company offers preclinical contract research services. It operates through the following business divisions: Customer Specific Research, Diagnostics, and TherapeuticS.

Executives

Prof. Dr. Andreas Pahl

Board of Directors

Heidelberg Pharma AG Headlines

No Headlines